Loading provider…
Loading provider…
Rheumatology Physician in Jacksonville, FL
NPI: 1457319741Primary Practice Location
SHANDS JACKSONVILLE
655 W 8th St, Jacksonville, FL
Primary Employer
University of Florida Jacksonville Physicians, Inc.
ufhealthjax.org
HQ Phone
Get MD Gurjit's Phone NumberMobile
Get MD Gurjit's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWA State Medical License
FL State Medical License
FL State Medical License
2008 - 2026
WA State Medical License
1998 - 2017

American Board of Internal Medicine
Rheumatology
University of Tennessee
Fellowship • Rheumatology
1996 - 1998
Residency • Internal Medicine
1994 - 1997
University of London Faculty of Medicine
Medical School
Until 1990
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 126 | 279 |
| 2 | 76881Complete ultrasound scan of joint | 51 | 73 |
| 3 | 76882Ultrasound of arm or leg | 20 | 28 |
| 4 | G0008Administration of influenza virus vaccine | 13 | 13 |
| 5 | J1040Injection, methylprednisolone acetate, 80 mg | 11 | 19 |
Diagnostic accuracy of salivary gland ultrasound in Sjögren's syndrome: A systematic review and meta-analysis.
Authors: Jasvinder Singh, Karishma Ramsubeik, Laurie Ramrattan
Publication Date: 2020-11
A rare case of aortitis and occlusive iliac thrombus due to Campylobacter fetus bacteremia.
Authors: Malleswari Ravi
Publication Date: 2025-01-15
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: GSK3196165 (Otilimab), DRUG: Tofacitinib 5 mg
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: BIOLOGICAL: Otilimab (GSK3196165), DRUG: csDMARD(s)
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: csDMARDs, BIOLOGICAL: GSK3196165 (Otilimab), BIOLOGICAL: Sarilumab, DRUG: Placebo to GSK3196165/ Sarilumab